ConductScience.org, home

Trial · NCT00843284

Results by group72

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Always8participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Most of the time14participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Fairly often57participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Sometimes199participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Rarely186participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Never183participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Missing0participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at baseline: Not done21participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Always27participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Most of the time152participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Fairly often168participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Sometimes176participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Rarely72participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Never37participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Missing1participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q1 at final visit: Not done35participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q2 at baseline: Always5participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q2 at baseline: Most of the time15participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q2 at baseline: Fairly often62participants
Anxiety and Depression SymptomsPregabalin (150 mg to 600 mg Per Day in 2 to 3 Divided Doses)Q2 at baseline: Sometimes150participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00843284/results